ADAR1 Capital Management »

Ovid Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $50k 16k 3.05
2023-12-31 $43k 13k 3.22

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Ovid Therapeutics

Rubric Capital Management
BlackRock
BlackRock
BVF
Vanguard Group
Siren
Acadian Asset Management
Kennedy Capital Management
Jpmorgan Chase & Co
Driehaus Capital Management
State Street Corporation
Geode Capital Management
TLS Advisors
Wells Fargo & Company
Northern Trust

View all funds holding Ovid Therapeutics